81232 Dpyd gene common variants
Also known as: DPYD pharmacogenetic testing, 5-FU sensitivity testing
Molecular analysis of the DPYD gene to identify common variants affecting 5-fluorouracil (chemotherapy drug) metabolism.
In Plain Language
chemotherapy sensitivity test; drug metabolism genetic testing
Clinical Context
Used to identify DPYD-deficient patients at high risk for severe 5-fluorouracil toxicity before cancer chemotherapy initiation.
RVU Information
CPT 81232 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81232?
CPT 81232 (Dpyd gene common variants) is a Pathology & Lab code. Molecular analysis of the DPYD gene to identify common variants affecting 5-fluorouracil (chemotherapy drug) metabolism.
Who uses CPT code 81232?
CPT 81232 is used by Oncology, Pathology, Pharmacology. Used to identify DPYD-deficient patients at high risk for severe 5-fluorouracil toxicity before cancer chemotherapy initiation.
When is CPT 81232 used?
Used to identify DPYD-deficient patients at high risk for severe 5-fluorouracil toxicity before cancer chemotherapy initiation.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.